stem cells « Science and Enterprise

Synthetic Bio Company Manufactures Research Cells

By Alan, on June 15th, 2023%

A synthetic biology company says it can now produce engineered cells from stem cells for research to precise specifications, and in large quantities and consistent quality. . . . → Read More: Synthetic Bio Company Manufactures Research Cells

T-Cell Biotech Gains €17.5M in Grant, Equity Funds

By Alan, on March 30th, 2023%

A developer of engineered immune cells to treat cancer and immune deficiencies is raising €17.5 million ($US 19.1 million) in equity and grant funding from an EU agency. . . . → Read More: T-Cell Biotech Gains €17.5M in Grant, Equity Funds

Human Ovary Organoid Model Demonstrated, Licensed

By Alan, on February 21st, 2023%

A university lab created and licensed to a biotechnology company a model human ovary made of functioning cells for female reproductive health applications. . . . → Read More: Human Ovary Organoid Model Demonstrated, Licensed

Implanted Organoid Connects to Brain, Reacts to Visual Cues

By Alan, on December 29th, 2022%

Engineers and neuroscientists developed a circuit that in lab mice connects implanted lab-grown brain tissue to the brain’s cognitive center and responds to visual stimuli. . . . → Read More: Implanted Organoid Connects to Brain, Reacts to Visual Cues

Bone Regeneration Experiment Begun on Space Station

By Alan, on December 12th, 2022%

An experiment is underway testing a bone repair biomaterial in lab mice under weightless conditions on the International Space Station. . . . → Read More: Bone Regeneration Experiment Begun on Space Station

Grant Funds Regenerative Gel for Treating Skin Ulcers

By Alan, on October 24th, 2022%

A California state research agency is funding preclinical development of a gel designed to regenerate stem cells in the skin to help heal venous skin ulcers. . . . → Read More: Grant Funds Regenerative Gel for Treating Skin Ulcers

Hydrogel Biomaterials Company Raises $3M in Early Funds

By Alan, on October 13th, 2022%

A developer of bioactive hydrogels as alternatives to animal models for drug discovery and clinical lab tests is raising $3 million in its first venture round. . . . → Read More: Hydrogel Biomaterials Company Raises $3M in Early Funds

Gene Therapy Stimulates Missing Enzymes in Rare Disease

By Alan, on October 11th, 2022%

Results from a clinical trial show an experimental gene therapy for Krabbe disease is safe and produces enzymes missing in children with the rare disease. . . . → Read More: Gene Therapy Stimulates Missing Enzymes in Rare Disease

Stem Cell Lab Planned for Commercial Space Station

By Alan, on September 29th, 2022%

A collaboration between university researchers and a space science company is designing a stem cell research lab on a proposed commercial space station. . . . → Read More: Stem Cell Lab Planned for Commercial Space Station

Venture to Build Cell, Gene Therapy Businesses

By Alan, on August 31st, 2022%

A joint venture with business development and bio-manufacturing companies aims to build new cell and gene therapy businesses to advance treatments from Mayo Clinic labs. . . . → Read More: Venture to Build Cell, Gene Therapy Businesses

Subscribe for email alerts

Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Like us on Facebook

Specials

Guest Posts

Please share Science & Enterprise